Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (10): 1008-1010.DOI: 10.3969/j.issn.1673-8640.2015.10.011
Previous Articles Next Articles
Received:2015-02-15
Online:2015-10-30
Published:2015-11-04
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.10.011
| 组别 | 例数 | PT(s) | TT(s) | APTT(s) | INR | Fib(g/L) |
|---|---|---|---|---|---|---|
| 治疗前 | 36 | 23.27±0.92 | 24.68±5.04 | 61.50±9.24 | 2.32±0.37 | 1.31±0.13 |
| 治疗后 | 36 | 18.8±0.85 | 18.49±2.48 | 44.25±6.98 | 1.51±0.23 | 1.36±0.18 |
| t值 | 5.92 | 4.846 | 7.644 | 8.379 | 1.479 | |
| P值 | <0.05 | <0.05 | <0.05 | <0.05 | >0.05 |
| 组别 | 例数 | PT(s) | TT(s) | APTT(s) | INR | Fib(g/L) |
|---|---|---|---|---|---|---|
| 治疗前 | 36 | 23.27±0.92 | 24.68±5.04 | 61.50±9.24 | 2.32±0.37 | 1.31±0.13 |
| 治疗后 | 36 | 18.8±0.85 | 18.49±2.48 | 44.25±6.98 | 1.51±0.23 | 1.36±0.18 |
| t值 | 5.92 | 4.846 | 7.644 | 8.379 | 1.479 | |
| P值 | <0.05 | <0.05 | <0.05 | <0.05 | >0.05 |
| 组别 | 例数 | TP(g/L) | Alb(g/L) | TBil(μmol/L) | ALT(U/L) |
|---|---|---|---|---|---|
| 治疗前 | 36 | 55.87±3.44 | 29.09±2.61 | 495.13±25.88 | 561.34±75.86 |
| 治疗后 | 36 | 57.63±4.25 | 31.07±2.53 | 216.63±29.78 | 76.48±10.85 |
| t值 | 1.592 | 2.194 | 8.15 | 6.177 | |
| P值 | >0.05 | <0.05 | <0.05 | <0.05 | |
| 组别 | 例数 | AST(U/L) | CHE(U/L) | BUN(mmol/L) | |
| 治疗前 | 36 | 456.61±135.30 | 3976.86±808.48 | 10.68±1.78 | |
| 治疗后 | 36 | 90.76±24.40 | 5 843.52±774.64 | 8.18±1.95 | |
| t值 | 11.83 | 10.38 | 4.60 | ||
| P值 | <0.05 | <0.05 | <0.05 | ||
| 组别 | 例数 | TP(g/L) | Alb(g/L) | TBil(μmol/L) | ALT(U/L) |
|---|---|---|---|---|---|
| 治疗前 | 36 | 55.87±3.44 | 29.09±2.61 | 495.13±25.88 | 561.34±75.86 |
| 治疗后 | 36 | 57.63±4.25 | 31.07±2.53 | 216.63±29.78 | 76.48±10.85 |
| t值 | 1.592 | 2.194 | 8.15 | 6.177 | |
| P值 | >0.05 | <0.05 | <0.05 | <0.05 | |
| 组别 | 例数 | AST(U/L) | CHE(U/L) | BUN(mmol/L) | |
| 治疗前 | 36 | 456.61±135.30 | 3976.86±808.48 | 10.68±1.78 | |
| 治疗后 | 36 | 90.76±24.40 | 5 843.52±774.64 | 8.18±1.95 | |
| t值 | 11.83 | 10.38 | 4.60 | ||
| P值 | <0.05 | <0.05 | <0.05 | ||
| [1] | 中华医学会传染病与寄生虫病学分会主任委员. 病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. |
| [2] | 中华医学会感染病学分会肝衰竭与人工肝学组. 非生物型人工肝支持系统治疗肝衰竭指南(2009年版)[J]. 中华临床感染病杂志,2009,2(6):321-325. |
| [3] | 周建英,刘涛,刘海东.血浆置换对重型病毒性肝炎患者凝血功能指标的影响[J].透析与人工器官,2008,19(1):20-22. |
| [4] | 邱洁,冯艳红,张永臣,等.肝衰竭患者人工肝血浆置换前后凝血功能指标变化观察[J].安徽医药,2009,13(7):758-759. |
| [5] | 李兰娟,黄建荣,陈月美,等.人工肝支持系统治疗重症肝炎临床应用研究[J].中华传染病杂志,1999,17(4):11-13. |
| [6] | HAMAGUCHI M.Artificial liver support system:removal of bilirubin and bile acids by hemoperfusion with ionex-column[J].Nihon Geka Gakkai Zasshi,1983,84(1):63-73. |
| [7] | YOSHIBA M,LNOUE K,SEKIYAMA K,et al.Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure[J].Artif Organs,1996,20(11):1169-1172. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
